 |
Previous Article | Next Article 
Volume 16, Number 15,
Issue of August 1, 1996
pp. 4810-4815
Copyright ©1996 Society for Neuroscience
Comparative Study of Pre- and Postsynaptic 5-HT1A
Receptor Modulation of Anxiety in Two Ethological Animal Tests
Received March 4, 1996; revised April 30, 1996; accepted May 13, 1996.
Sandra E. File,
Luis E. Gonzalez, and
Nick Andrews
Psychopharmacology Research Unit, United Medical and Dental Schools
of Guy's and St. Thomas's Hospitals Division of Pharmacology, Guy's
Hospital, London SE1 9RT, United Kingdom
The purpose of this study was to determine the roles of the
presynaptic 5-hydroxytryptamine1A
(5-HT1A) receptors in the median raphé
nucleus (MRN) and of the postsynaptic 5-HT1A
receptors in its projection area of the dorsal hippocampus in the
social interaction and elevated plus-maze tests of anxiety. Direct
administration of the 5-HT1A receptor agonist
(±)-8-hydroxy-dipropylaminotetralin (8-OH-DPAT, 200 ng) into the MRN
had significant anxiolytic effects in all three test situations
examined (social interaction, plus-maze trials 1 and 2). These
anxiolytic effects were antagonized by a silent dose (200 ng) of the
5-HT1A receptor antagonist WAY 100635, confirming
that they were mediated by 5-HT1A receptors. In
contrast, after bilateral administration to the dorsal hippocampus,
8-OH-DPAT (100 ng) had significant anxiogenic effects in the social
interaction test and in plus-maze trial 2. These anxiogenic effects
were antagonized by silent doses of 5-HT1A
receptor antagonists [(+)WAY 100135, 10 mg/kg s.c., and
intrahippocampal (±)tertatolol, 3 µg, respectively], confirming
mediation by 5-HT1A receptors. In rats naive to
the plus-maze, neither 8-OH-DPAT (50, 100, or 200 ng) nor the
5-HT1A receptor antagonist (±)tertatolol (3 µg) had any significant effect when administered to the dorsal
hippocampus. This demonstrates that previous experience of a rat in the
plus-maze has a major effect on the sensitivity of dorsal hippocampal
5-HT1A receptors, as we have demonstrated
previously for the 5-HT1A receptors in the dorsal
raphé nucleus. Overall, our results provide evidence that
stimulation of the presynaptic 5-HT1A receptors
in the MRN results in an anxiolytic action, whereas stimulation of the
post-synaptic 5-HT1A receptors in its projection
area results in an anxiogenic effect. These results are consistent with
an overall reduction in 5-HT neurotransmission in the dorsal
hippocampus having an anxiolytic effect, and they explain the
relatively weak anxiolytic profile detected when
5-HT1A receptor agonists are given
systemically.
Key words:
5-HT1A;
hippocampus;
median
raphé nucleus;
elevated plus-maze;
social interaction;
anxiety
This article has been cited by other articles:

|
 |

|
 |
 
J. A. Gordon, C. O. Lacefield, C. G. Kentros, and R. Hen
State-Dependent Alterations in Hippocampal Oscillations in Serotonin 1A Receptor-Deficient Mice
J. Neurosci.,
July 13, 2005;
25(28):
6509 - 6519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Rubin, D. B. Berlese, J. A. Stiegemeier, M. A. Volkweis, D. M. Oliveira, T. L. B. dos Santos, A. C. Fenili, and C. F. Mello
Intra-Amygdala Administration of Polyamines Modulates Fear Conditioning in Rats
J. Neurosci.,
March 3, 2004;
24(9):
2328 - 2334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. van den Berg, S. A. Versteeg, and B. A. van Oost
Isolation and Characterization of the Canine Serotonin Receptor 1A Gene (htr1A)
J. Hered.,
January 1, 2003;
94(1):
49 - 56.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Millan, M. Brocco, A. Gobert, R. Schreiber, and A. Dekeyne
S-16924 [(R)-2-{1-[2-(2,3-Dihydro-benzo[1,4]dioxin-5-yloxy)-ethyl]-pyrrolidin-3yl}-1-(4-fluorophenyl)-ethanone], a Novel, Potential Antipsychotic with Marked Serotonin1A Agonist Properties: III. Anxiolytic Actions in Comparison with Clozapine and Haloperidol
J. Pharmacol. Exp. Ther.,
March 1, 1999;
288(3):
1002 - 1014.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. A. Nitz and B. L. McNaughton
Hippocampal EEG and Unit Activity Responses to Modulation of Serotonergic Median Raphe Neurons in the Freely Behaving Rat
Learn. Mem.,
March 1, 1999;
6(2):
153 - 167.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. K. Heisler, H.-M. Chu, T. J. Brennan, J. A. Danao, P. Bajwa, L. H. Parsons, and L. H. Tecott
Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice
PNAS,
December 8, 1998;
95(25):
15049 - 15054.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ramboz, R. Oosting, D. A. Amara, H. F. Kung, P. Blier, M. Mendelsohn, J. J. Mann, D. Brunner, and R. Hen
Serotonin receptor 1A knockout: An animal model of anxiety-related disorder
PNAS,
November 24, 1998;
95(24):
14476 - 14481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Balcells-Olivero, M. S. Cousins, and L. S. Seiden
Holtzman and Harlan Sprague-Dawley Rats: Differences in DRL 72-Sec Performance and 8-Hydroxy-Di-Propylamino Tetralin-Induced Hypothermia
J. Pharmacol. Exp. Ther.,
August 1, 1998;
286(2):
742 - 752.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A.L. Vale, S. Green, A.M.J. Montgomery, and S. Shafi
The nitric oxide synthesis inhibitor L-NAME produces anxiogenic-like effects in the rat elevated plus-maze test, but not in the social interaction test
J Psychopharmacol,
January 1, 1998;
12(3):
268 - 272.
[Abstract]
[PDF]
|
 |
|
|